Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

7-(2-Hydroxyethyl)guanosine Inhibitors

7-(2-Hydroxyethyl)guanosine inhibitors are a class of chemical compounds specifically designed to inhibit the activity of molecules containing the modified nucleoside 7-(2-hydroxyethyl)guanosine. This nucleoside derivative arises from the attachment of a hydroxyethyl group to the nitrogenous base guanine at the N7 position, altering its chemical properties and interactions within nucleic acids. Inhibitors of 7-(2-hydroxyethyl)guanosine are structured to block or interfere with the biological functions of this modified nucleoside, particularly in processes such as RNA and DNA metabolism. These inhibitors may bind directly to 7-(2-hydroxyethyl)guanosine residues within nucleic acids or target enzymes responsible for recognizing or incorporating this modified base into RNA or DNA strands, disrupting the normal processing and regulation of genetic material.

7-(2-hydroxyethyl)guanosine inhibitors are highly selective, ensuring precise interaction with their target without affecting other nucleosides or their analogs. Their structure often incorporates functional groups that enable strong binding to the hydroxyethyl group or to key recognition elements within nucleic acid-processing enzymes. This specificity allows researchers to probe the unique role that 7-(2-hydroxyethyl)guanosine plays in nucleic acid structure and function, particularly in the context of modifications that influence RNA stability, translation, and protein synthesis. By inhibiting these pathways, these compounds contribute to a deeper understanding of how modified nucleosides like 7-(2-hydroxyethyl)guanosine impact the regulation of gene expression and the broader molecular machinery involved in RNA and DNA processes.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ribavirin

36791-04-5sc-203238
sc-203238A
sc-203238B
10 mg
100 mg
5 g
$62.00
$108.00
$210.00
1
(1)

A guanosine analog that inhibits inosine monophosphate dehydrogenase, can alter guanosine triphosphate pools and therefore indirectly impact pathways involving 7-(2-Hydroxyethyl)guanosine.

Mycophenolic acid

24280-93-1sc-200110
sc-200110A
100 mg
500 mg
$68.00
$261.00
8
(1)

Inhibits inosine monophosphate dehydrogenase, potentially affecting guanosine nucleotide synthesis and indirectly impacting the levels of 7-(2-Hydroxyethyl)guanosine.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$92.00
$209.00
33
(5)

Dihydrofolate reductase inhibitor, can reduce the availability of one-carbon units necessary for purine synthesis, indirectly affecting 7-(2-Hydroxyethyl)guanosine levels.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$36.00
$149.00
11
(1)

Inhibits thymidylate synthase, which can lead to a nucleotide imbalance and indirectly affect pathways involving 7-(2-Hydroxyethyl)guanosine.

6-Thioguanine

154-42-7sc-205587
sc-205587A
250 mg
500 mg
$41.00
$53.00
3
(1)

A guanine analog that can be incorporated into DNA and RNA, potentially disrupting enzymes that interact with 7-(2-Hydroxyethyl)guanosine.

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$76.00
$255.00
18
(1)

Inhibits ribonucleotide reductase, which can lower deoxyribonucleotide levels and indirectly affect 7-(2-Hydroxyethyl)guanosine.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A cytidine analog that can be incorporated into RNA and DNA, possibly affecting methylation patterns and indirectly influencing 7-(2-Hydroxyethyl)guanosine pathways.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

A deoxycytidine analog that can inhibit DNA methyltransferases, potentially altering methylation patterns and indirectly affecting 7-(2-Hydroxyethyl)guanosine.

Allopurinol

315-30-0sc-207272
25 g
$128.00
(0)

Inhibitor of xanthine oxidase, can reduce the conversion of hypoxanthine to xanthine and uric acid, indirectly affecting purine metabolism and 7-(2-Hydroxyethyl)guanosine.

Tiazofurin

60084-10-8sc-475805
5 mg
$440.00
(0)

Inhibits IMP dehydrogenase leading to lowered guanosine nucleotide concentrations, which may impact the availability and function of 7-(2-Hydroxyethyl)guanosine.